These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20644444)

  • 1. How and when to use DMARDs.
    Simmons S
    Nurse Pract; 2010 Aug; 35(8):12-4. PubMed ID: 20644444
    [No Abstract]   [Full Text] [Related]  

  • 2. H1N1 virus and vaccination among rheumatology patients, especially those on DMARDS.
    O'Connor MB; Rathi J; Bond U; Swan J; Phelan M
    Ir Med J; 2010 Apr; 103(4):126-7. PubMed ID: 20491149
    [No Abstract]   [Full Text] [Related]  

  • 3. The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelines.
    Deighton C; Gadsby K
    Musculoskeletal Care; 2006 Sep; 4(3):174-81. PubMed ID: 17042028
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnosis and management of juvenile idiopathic arthritis.
    Stanley LC; Ward-Smith P
    J Pediatr Health Care; 2011; 25(3):191-4. PubMed ID: 21514495
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheumatology. 3. Modern drug therapies and current guidelines in rheumatology nursing.
    Hill J; Reay N
    Nurs Times; 2002 Mar 7-13; 98(10):41-4. PubMed ID: 11921625
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists.
    Gossec L; Bijlsma JW; Bombardier C; Canhão H; Devlin J; Edwards CJ; Hamuryudan V; Kvien TK; Leeb BF; Martín-Mola EM; Mielants H; Müller-Ladner U; Ostergaard M; Pereira IA; Ramos-Remus C; Zochling J; Dougados M
    Ann Rheum Dis; 2011 Feb; 70(2):388-9. PubMed ID: 20472594
    [No Abstract]   [Full Text] [Related]  

  • 7. [Attitude of patient associations to clinical trials of new drugs].
    Tybkjaer HW; Witte L; Johannessen MB
    Ugeskr Laeger; 2003 Apr; 165(16):1688-90. PubMed ID: 12756833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
    Ledingham J; Gullick N; Irving K; Gorodkin R; Aris M; Burke J; Gordon P; Christidis D; Galloway S; Hayes E; Jeffries A; Mercer S; Mooney J; van Leuven S; Galloway J;
    Rheumatology (Oxford); 2017 Jun; 56(6):865-868. PubMed ID: 28339817
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.
    Seidman EG; Furst DE
    J Rheumatol; 2002 Dec; 29(12):2484-7. PubMed ID: 12465139
    [No Abstract]   [Full Text] [Related]  

  • 10. [News in rheumatology. The Danish Society of Rheumatology].
    Østergaard M; Steengaard-Pedersen K; Herlin T; Kjaer M; Døhn UM; Nørregaard J; Madsen OR;
    Ugeskr Laeger; 2007 Mar; 169(12):1131. PubMed ID: 17394842
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescribing guidelines based on a flexible scope of practice.
    Nejedly MP; Broden K; Knox SC; Jennings AF; Logan M; Macy ML; Manning SK; Mendoza DC; Mohler KL; Quaglietti SE; Thrailkill AM
    Clin Excell Nurse Pract; 1999 Mar; 3(2):73-9. PubMed ID: 10646394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for use of antirheumatic drugs.
    Russell AS; Darmawan J; Scott DL; Brooks PM; Hubscher O
    J Rheumatol Suppl; 1994 Sep; 41():79-81. PubMed ID: 7799391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic of antirheumatic treatments: clinical implications.
    Ferraccioli G; Tolusso B; De Santis M
    Pharmacogenomics J; 2007 Feb; 7(1):2-9. PubMed ID: 16702980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatology: the expectations and preferences of patients for their follow-up monitoring care: a qualitative study to determine the dimensions of patient satisfaction.
    Arthur V; Clifford C
    J Clin Nurs; 2004 Feb; 13(2):234-42. PubMed ID: 14723676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risks of Cox-2-antagonists. Opinion on the marketed name rofecoxib, and its market-withdrawn valdecoxib and the actual therapeutic restrictions].
    Bolten WW; Reiter S;
    Z Rheumatol; 2005 May; 64(4):286-9. PubMed ID: 15909092
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic strategies: Ways to remission].
    Krüger K; Edelmann E
    Z Rheumatol; 2015 Jun; 74(5):386-7. PubMed ID: 26085071
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug therapy in adolescents with rheumatic diseases.
    Schaller JG
    Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):194S-195S. PubMed ID: 9385680
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatic diseases should be actively treated in pregnancy, new guidelines say.
    Wise J
    BMJ; 2016 Jan; 532():i312. PubMed ID: 26787749
    [No Abstract]   [Full Text] [Related]  

  • 19. [Patient safety first. position paper of the German Rheumatism -- Ligazur introduction of biosimilars].
    Z Rheumatol; 2014 Sep; 73(7):676. PubMed ID: 25320752
    [No Abstract]   [Full Text] [Related]  

  • 20. Antirheumatic drug therapy during pregnancy.
    Soscia PN; Zurier RB
    Bull Rheum Dis; 1997 Apr; 46(2):2-4. PubMed ID: 9104043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.